Loading…

Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions

Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic p...

Full description

Saved in:
Bibliographic Details
Published in:Investigative ophthalmology & visual science 2014-08, Vol.55 (9), p.6024-6030
Main Authors: Koopmans, Anna E, Ober, Kimberley, Dubbink, Hendrikus J, Paridaens, Dion, Naus, Nicole C, Belunek, Stephan, Krist, Bart, Post, Edward, Zwarthoff, Ellen C, de Klein, Annelies, Verdijk, Robert M
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3
cites
container_end_page 6030
container_issue 9
container_start_page 6024
container_title Investigative ophthalmology & visual science
container_volume 55
creator Koopmans, Anna E
Ober, Kimberley
Dubbink, Hendrikus J
Paridaens, Dion
Naus, Nicole C
Belunek, Stephan
Krist, Bart
Post, Edward
Zwarthoff, Ellen C
de Klein, Annelies
Verdijk, Robert M
description Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic precursor lesion primary acquired melanosis (PAM). We tested a cohort of uveal and conjunctival melanomas as well as conjunctival benign and premalignant melanocytic lesions for TERT promoter mutations in order to elucidate the role of these mutations in tumor progression. TERT promoter mutation analysis on fresh tumor DNA and DNA from formalin-fixed, paraffin-embedded specimens was performed by SNaPshot analysis in 102 uveal melanomas, 39 conjunctival melanomas, 26 PAM with atypia, 14 PAM without atypia, and 56 conjunctival nevi. Mutations of the TERT promoter were not identified in conjunctival nevi or PAM without atypia, but were detected in 2/25 (8%) of PAM with atypia and 16/39 (41%) of conjunctival melanomas. A single TERT promoter mutation was detected in 102 uveal melanomas (1%). We present the second documented case of TERT promoter mutation in uveal melanoma. In comparison with other types of melanoma, TERT promoter mutations occur at extremely low frequency in uveal melanoma. TERT promoter mutations are frequent in conjunctival melanoma and occur at lower frequency in PAM with atypia but were not detected in benign conjunctival melanocytic lesions. These findings favor a pathogenetic tumor progression role for TERT promoter mutations in conjunctival melanocytic lesions.
doi_str_mv 10.1167/iovs.14-14901
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566402913</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1566402913</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3</originalsourceid><addsrcrecordid>eNptUU1PwzAMjRCIjcGRK8qRS0ecfuaIpvEhTQKhca5SN0WZmqQ07aT9E34uXTcQB0625edn-z1CroHNAZL0Trutn0MUQCQYnJApxDEP4jQLT__kE3Lh_YYxDsDZOZnwGGLBWTwlX6-t2spaWVRU2pJq09QaZaed9dRVdL18W9OmdcZ1qqWm78YW1Zb2WyXrcQad3fQWOz0QUaNqaZ2RBzZLC2X1hx2rplVG1kMlbfffEO46jbRWfr_8kpxVsvbq6hhn5P1huV48BauXx-fF_SpALsIuqCoRpTzhIAHTtBCiFFnJUiGQ8wKSKBskSCTKIlKsKLICwxgxYxx5EmIYYTgjtwfe4cnPXvkuN9qjqoeDlOt9DnGSRIwLCAdocIBi67xvVZU3rTay3eXA8r0Z-d6MHKJ8NGPA3xyp-8Ko8hf9o374DUZ9iWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566402913</pqid></control><display><type>article</type><title>Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions</title><source>PubMed (Medline)</source><creator>Koopmans, Anna E ; Ober, Kimberley ; Dubbink, Hendrikus J ; Paridaens, Dion ; Naus, Nicole C ; Belunek, Stephan ; Krist, Bart ; Post, Edward ; Zwarthoff, Ellen C ; de Klein, Annelies ; Verdijk, Robert M</creator><creatorcontrib>Koopmans, Anna E ; Ober, Kimberley ; Dubbink, Hendrikus J ; Paridaens, Dion ; Naus, Nicole C ; Belunek, Stephan ; Krist, Bart ; Post, Edward ; Zwarthoff, Ellen C ; de Klein, Annelies ; Verdijk, Robert M ; Rotterdam Ocular Melanoma Study Group</creatorcontrib><description>Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic precursor lesion primary acquired melanosis (PAM). We tested a cohort of uveal and conjunctival melanomas as well as conjunctival benign and premalignant melanocytic lesions for TERT promoter mutations in order to elucidate the role of these mutations in tumor progression. TERT promoter mutation analysis on fresh tumor DNA and DNA from formalin-fixed, paraffin-embedded specimens was performed by SNaPshot analysis in 102 uveal melanomas, 39 conjunctival melanomas, 26 PAM with atypia, 14 PAM without atypia, and 56 conjunctival nevi. Mutations of the TERT promoter were not identified in conjunctival nevi or PAM without atypia, but were detected in 2/25 (8%) of PAM with atypia and 16/39 (41%) of conjunctival melanomas. A single TERT promoter mutation was detected in 102 uveal melanomas (1%). We present the second documented case of TERT promoter mutation in uveal melanoma. In comparison with other types of melanoma, TERT promoter mutations occur at extremely low frequency in uveal melanoma. TERT promoter mutations are frequent in conjunctival melanoma and occur at lower frequency in PAM with atypia but were not detected in benign conjunctival melanocytic lesions. These findings favor a pathogenetic tumor progression role for TERT promoter mutations in conjunctival melanocytic lesions.</description><identifier>ISSN: 1552-5783</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.14-14901</identifier><identifier>PMID: 25159205</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Conjunctival Neoplasms - epidemiology ; Conjunctival Neoplasms - genetics ; Conjunctival Neoplasms - pathology ; Disease Progression ; Female ; Humans ; Male ; Melanoma - epidemiology ; Melanoma - genetics ; Melanoma - pathology ; Melanosis - epidemiology ; Melanosis - genetics ; Melanosis - pathology ; Middle Aged ; Neoplasms - epidemiology ; Neoplasms - genetics ; Neoplasms - pathology ; Nevus, Pigmented - epidemiology ; Nevus, Pigmented - genetics ; Nevus, Pigmented - pathology ; Precancerous Conditions - epidemiology ; Precancerous Conditions - genetics ; Precancerous Conditions - pathology ; Prevalence ; Promoter Regions, Genetic - genetics ; Telomerase - genetics ; Uveal Neoplasms - epidemiology ; Uveal Neoplasms - genetics ; Uveal Neoplasms - pathology ; Young Adult</subject><ispartof>Investigative ophthalmology &amp; visual science, 2014-08, Vol.55 (9), p.6024-6030</ispartof><rights>Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25159205$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koopmans, Anna E</creatorcontrib><creatorcontrib>Ober, Kimberley</creatorcontrib><creatorcontrib>Dubbink, Hendrikus J</creatorcontrib><creatorcontrib>Paridaens, Dion</creatorcontrib><creatorcontrib>Naus, Nicole C</creatorcontrib><creatorcontrib>Belunek, Stephan</creatorcontrib><creatorcontrib>Krist, Bart</creatorcontrib><creatorcontrib>Post, Edward</creatorcontrib><creatorcontrib>Zwarthoff, Ellen C</creatorcontrib><creatorcontrib>de Klein, Annelies</creatorcontrib><creatorcontrib>Verdijk, Robert M</creatorcontrib><creatorcontrib>Rotterdam Ocular Melanoma Study Group</creatorcontrib><title>Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions</title><title>Investigative ophthalmology &amp; visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic precursor lesion primary acquired melanosis (PAM). We tested a cohort of uveal and conjunctival melanomas as well as conjunctival benign and premalignant melanocytic lesions for TERT promoter mutations in order to elucidate the role of these mutations in tumor progression. TERT promoter mutation analysis on fresh tumor DNA and DNA from formalin-fixed, paraffin-embedded specimens was performed by SNaPshot analysis in 102 uveal melanomas, 39 conjunctival melanomas, 26 PAM with atypia, 14 PAM without atypia, and 56 conjunctival nevi. Mutations of the TERT promoter were not identified in conjunctival nevi or PAM without atypia, but were detected in 2/25 (8%) of PAM with atypia and 16/39 (41%) of conjunctival melanomas. A single TERT promoter mutation was detected in 102 uveal melanomas (1%). We present the second documented case of TERT promoter mutation in uveal melanoma. In comparison with other types of melanoma, TERT promoter mutations occur at extremely low frequency in uveal melanoma. TERT promoter mutations are frequent in conjunctival melanoma and occur at lower frequency in PAM with atypia but were not detected in benign conjunctival melanocytic lesions. These findings favor a pathogenetic tumor progression role for TERT promoter mutations in conjunctival melanocytic lesions.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Conjunctival Neoplasms - epidemiology</subject><subject>Conjunctival Neoplasms - genetics</subject><subject>Conjunctival Neoplasms - pathology</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Melanoma - epidemiology</subject><subject>Melanoma - genetics</subject><subject>Melanoma - pathology</subject><subject>Melanosis - epidemiology</subject><subject>Melanosis - genetics</subject><subject>Melanosis - pathology</subject><subject>Middle Aged</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - pathology</subject><subject>Nevus, Pigmented - epidemiology</subject><subject>Nevus, Pigmented - genetics</subject><subject>Nevus, Pigmented - pathology</subject><subject>Precancerous Conditions - epidemiology</subject><subject>Precancerous Conditions - genetics</subject><subject>Precancerous Conditions - pathology</subject><subject>Prevalence</subject><subject>Promoter Regions, Genetic - genetics</subject><subject>Telomerase - genetics</subject><subject>Uveal Neoplasms - epidemiology</subject><subject>Uveal Neoplasms - genetics</subject><subject>Uveal Neoplasms - pathology</subject><subject>Young Adult</subject><issn>1552-5783</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNptUU1PwzAMjRCIjcGRK8qRS0ecfuaIpvEhTQKhca5SN0WZmqQ07aT9E34uXTcQB0625edn-z1CroHNAZL0Trutn0MUQCQYnJApxDEP4jQLT__kE3Lh_YYxDsDZOZnwGGLBWTwlX6-t2spaWVRU2pJq09QaZaed9dRVdL18W9OmdcZ1qqWm78YW1Zb2WyXrcQad3fQWOz0QUaNqaZ2RBzZLC2X1hx2rplVG1kMlbfffEO46jbRWfr_8kpxVsvbq6hhn5P1huV48BauXx-fF_SpALsIuqCoRpTzhIAHTtBCiFFnJUiGQ8wKSKBskSCTKIlKsKLICwxgxYxx5EmIYYTgjtwfe4cnPXvkuN9qjqoeDlOt9DnGSRIwLCAdocIBi67xvVZU3rTay3eXA8r0Z-d6MHKJ8NGPA3xyp-8Ko8hf9o374DUZ9iWA</recordid><startdate>20140826</startdate><enddate>20140826</enddate><creator>Koopmans, Anna E</creator><creator>Ober, Kimberley</creator><creator>Dubbink, Hendrikus J</creator><creator>Paridaens, Dion</creator><creator>Naus, Nicole C</creator><creator>Belunek, Stephan</creator><creator>Krist, Bart</creator><creator>Post, Edward</creator><creator>Zwarthoff, Ellen C</creator><creator>de Klein, Annelies</creator><creator>Verdijk, Robert M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140826</creationdate><title>Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions</title><author>Koopmans, Anna E ; Ober, Kimberley ; Dubbink, Hendrikus J ; Paridaens, Dion ; Naus, Nicole C ; Belunek, Stephan ; Krist, Bart ; Post, Edward ; Zwarthoff, Ellen C ; de Klein, Annelies ; Verdijk, Robert M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Conjunctival Neoplasms - epidemiology</topic><topic>Conjunctival Neoplasms - genetics</topic><topic>Conjunctival Neoplasms - pathology</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Melanoma - epidemiology</topic><topic>Melanoma - genetics</topic><topic>Melanoma - pathology</topic><topic>Melanosis - epidemiology</topic><topic>Melanosis - genetics</topic><topic>Melanosis - pathology</topic><topic>Middle Aged</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - pathology</topic><topic>Nevus, Pigmented - epidemiology</topic><topic>Nevus, Pigmented - genetics</topic><topic>Nevus, Pigmented - pathology</topic><topic>Precancerous Conditions - epidemiology</topic><topic>Precancerous Conditions - genetics</topic><topic>Precancerous Conditions - pathology</topic><topic>Prevalence</topic><topic>Promoter Regions, Genetic - genetics</topic><topic>Telomerase - genetics</topic><topic>Uveal Neoplasms - epidemiology</topic><topic>Uveal Neoplasms - genetics</topic><topic>Uveal Neoplasms - pathology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koopmans, Anna E</creatorcontrib><creatorcontrib>Ober, Kimberley</creatorcontrib><creatorcontrib>Dubbink, Hendrikus J</creatorcontrib><creatorcontrib>Paridaens, Dion</creatorcontrib><creatorcontrib>Naus, Nicole C</creatorcontrib><creatorcontrib>Belunek, Stephan</creatorcontrib><creatorcontrib>Krist, Bart</creatorcontrib><creatorcontrib>Post, Edward</creatorcontrib><creatorcontrib>Zwarthoff, Ellen C</creatorcontrib><creatorcontrib>de Klein, Annelies</creatorcontrib><creatorcontrib>Verdijk, Robert M</creatorcontrib><creatorcontrib>Rotterdam Ocular Melanoma Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Investigative ophthalmology &amp; visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koopmans, Anna E</au><au>Ober, Kimberley</au><au>Dubbink, Hendrikus J</au><au>Paridaens, Dion</au><au>Naus, Nicole C</au><au>Belunek, Stephan</au><au>Krist, Bart</au><au>Post, Edward</au><au>Zwarthoff, Ellen C</au><au>de Klein, Annelies</au><au>Verdijk, Robert M</au><aucorp>Rotterdam Ocular Melanoma Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions</atitle><jtitle>Investigative ophthalmology &amp; visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2014-08-26</date><risdate>2014</risdate><volume>55</volume><issue>9</issue><spage>6024</spage><epage>6030</epage><pages>6024-6030</pages><issn>1552-5783</issn><eissn>1552-5783</eissn><abstract>Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic precursor lesion primary acquired melanosis (PAM). We tested a cohort of uveal and conjunctival melanomas as well as conjunctival benign and premalignant melanocytic lesions for TERT promoter mutations in order to elucidate the role of these mutations in tumor progression. TERT promoter mutation analysis on fresh tumor DNA and DNA from formalin-fixed, paraffin-embedded specimens was performed by SNaPshot analysis in 102 uveal melanomas, 39 conjunctival melanomas, 26 PAM with atypia, 14 PAM without atypia, and 56 conjunctival nevi. Mutations of the TERT promoter were not identified in conjunctival nevi or PAM without atypia, but were detected in 2/25 (8%) of PAM with atypia and 16/39 (41%) of conjunctival melanomas. A single TERT promoter mutation was detected in 102 uveal melanomas (1%). We present the second documented case of TERT promoter mutation in uveal melanoma. In comparison with other types of melanoma, TERT promoter mutations occur at extremely low frequency in uveal melanoma. TERT promoter mutations are frequent in conjunctival melanoma and occur at lower frequency in PAM with atypia but were not detected in benign conjunctival melanocytic lesions. These findings favor a pathogenetic tumor progression role for TERT promoter mutations in conjunctival melanocytic lesions.</abstract><cop>United States</cop><pmid>25159205</pmid><doi>10.1167/iovs.14-14901</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1552-5783
ispartof Investigative ophthalmology & visual science, 2014-08, Vol.55 (9), p.6024-6030
issn 1552-5783
1552-5783
language eng
recordid cdi_proquest_miscellaneous_1566402913
source PubMed (Medline)
subjects Adult
Aged
Aged, 80 and over
Conjunctival Neoplasms - epidemiology
Conjunctival Neoplasms - genetics
Conjunctival Neoplasms - pathology
Disease Progression
Female
Humans
Male
Melanoma - epidemiology
Melanoma - genetics
Melanoma - pathology
Melanosis - epidemiology
Melanosis - genetics
Melanosis - pathology
Middle Aged
Neoplasms - epidemiology
Neoplasms - genetics
Neoplasms - pathology
Nevus, Pigmented - epidemiology
Nevus, Pigmented - genetics
Nevus, Pigmented - pathology
Precancerous Conditions - epidemiology
Precancerous Conditions - genetics
Precancerous Conditions - pathology
Prevalence
Promoter Regions, Genetic - genetics
Telomerase - genetics
Uveal Neoplasms - epidemiology
Uveal Neoplasms - genetics
Uveal Neoplasms - pathology
Young Adult
title Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A47%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20implications%20of%20TERT%20promoter%20mutation%20in%20uveal%20and%20conjunctival%20melanoma%20and%20in%20benign%20and%20premalignant%20conjunctival%20melanocytic%20lesions&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Koopmans,%20Anna%20E&rft.aucorp=Rotterdam%20Ocular%20Melanoma%20Study%20Group&rft.date=2014-08-26&rft.volume=55&rft.issue=9&rft.spage=6024&rft.epage=6030&rft.pages=6024-6030&rft.issn=1552-5783&rft.eissn=1552-5783&rft_id=info:doi/10.1167/iovs.14-14901&rft_dat=%3Cproquest_cross%3E1566402913%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1566402913&rft_id=info:pmid/25159205&rfr_iscdi=true